Dr Pall is Professor of Biochemistry and Basic Medical Sciences at Washington State University.

Dr Pall is Professor of Biochemistry and Basic Medical Sciences at Washington State University. He is generally writing a book called Explaining "Unexplained Illnesses."

for what reason did you become interested in researching this cluster of illnesses--MCS, Chronic Fatigue, Fibromyalgia, column Traumatic Stress Disorder?

I came down with a case of chronic fatigue syndrome (CFS) in the summer of 1997 Unlike chiefly CFS sufferers, I had a unimpaired recovery, over a period of about a year and a half. I decided to dedicate the stay of my scientific career to understanding the mechanisms causing this dispose of illnesses.

Who is at-risk for developing MCS? Is a genetic pre-disposition necessary? Is early front to toxic chemicals in pesticides and menstrums critical?

There is evidence for an important genetic character in determining one's tendency to finish each of these related illnesses. For MC the evidence in such a manner far implicates genes involved in chemical metabolism, as well as a gene that helps determine the activity of the NMDA receptors in the brain, receptors that I believe are central to the mechanism of MC I would wait for that a number of vitamins, magnesium, selenium and a variety of antioxidants may well have a part in preventing MCS. I think that in about individuals, early life stressors may well make them more susceptible to MC on the contrary in others this will not be a factor.

There are multiple short bourn stressors that are implicated in this whole clump of illnesses, including pesticides and volatile organic menstrums particularly in MCS, infection, particularly in CF the two infection and physical trauma (particularly head and neck trauma) in fibromyalgia and morose psychological stress in posttraumatic stres disorder. All of these stressors can create increases in nitric oxide and I have propos that they may trigger a for the use of all biochemical/physiological response that is responsible for these illnesses.

on what account is there so much variation of symptoms from single in kind individual to another within this clump of illnesses?

individual can explain many of the symptoms as being produc by the agency of impact on different regions of the brain, as well as different parts of the cessation of the body. For example, near people with MCS have lower lung asthma-like sensitivities, sometimes abbreviated RADS and about do not--and those who have this have tissue impact in the lower lung in such a manner a specific tissue when impacted from this biochemistry produces a specific response

Describe the focus of your work with these illnesses and the grants/funding sought

greatest in quantity of my work, over the past seven years or to such a degree has been trying to master large areas of the scientific literature to lay open the best possible theory of the etiologic (causal) mechanism of these illnesses. This does not require any outside funding and fortunately, my university has been satisfied to have me do this and has not "bugged" me to prosecute more grant funding.

This is the emblem of work that nobody does. The reason for that is two-fold Firstly, you cannot achieve research funding to do this prototype of work. Secondly it is damn hard work and mostly people do not have either the breadth of background or the interest in pursuing it. This is despite the fact that more [i]or[/i] less very prominent scientists have annotationed that this is just the prototype of work that we chiefly need in the biomedical area. We are inundated by the agency of experimental results in many areas of biomedical science (not in succession MCS, however) but have little time to integrate these follows into understandable conceptual frameworks.

I did have a small grant onward CFS, which allowed me to publish brace experimental papers providing support for my theory. I also tried to obtain funding for two similar trials, individual for CFS treatment and other for fibromyalgia treatment. The pair foundations that I went to for funding the pair had the same response. They felt that if the trial worked, we would not know for what cause [i]or[/i] reason it worked because there were likewise many components involved in the trial, and likewise the foundations were not interested in it. I gues I'd like them to make trial of to convince the sufferers that an effective treatment would not be worth supporting calm if one cannot determine exactly to what degree it works.

You've exhibited a treatment protocol that has a nutritional focus. Describe it.

First, give permission to me remind you that I am a PhD not an MD in such a manner nothing I write should be interpreted as a recommendation or as medical advice. I have been interested in therapy issues continually since I got involved with this cluster of illnesses. I think that any etiologic (causal) theory has got to display its value through its ability to move effective therapeutic approaches.

Dr Grace Ziem asked me to draw near up with a treatment protocol. She had my protocol mixed by a compounding pharmacy and is trying it upon her MCS patients. She reports it be seens to be substantially more effective than her previous treatment approaches.

The approach that I have taken is based forward the use of nutritional continuations rather than conventional pharmaceuticals, and this approach was taken for couple reasons. One is that there are not a fortune of conventional pharmaceuticals that are attractive candidates for therapy. Secondly Dr Ziem wanted us to use as natural an approach as possible, common that might give the injured carcass (including brain, of course) an opportunity to heal itself.